These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1570549)

  • 21. Current status of living-related liver transplantation.
    Hayashi M; Cao S; Concepcion W; Monge H; Ojogho O; So S; Esquivel CO
    Pediatr Transplant; 1998 Feb; 2(1):16-25. PubMed ID: 10084755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of eosinophils for therapeutic response in severe acute hepatic allograft rejection.
    Ben-Ari Z; Dhillon AP; Garwood L; Rolles K; Davidson B; Burroughs AK
    Transplant Proc; 1996 Dec; 28(6):3624-8. PubMed ID: 8962399
    [No Abstract]   [Full Text] [Related]  

  • 23. Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506.
    Velio P; Tarantino C; Bertoglio C; Guffanti E; Bardella MT; Biffi R; Andreoni B; Rossi G; Gatti S; Piazzini A; Fassati LR; Galmarini D
    Transplant Proc; 1996 Oct; 28(5):2529-30. PubMed ID: 8907936
    [No Abstract]   [Full Text] [Related]  

  • 24. Severity of liver transplantation rejection is associated with recipient HLA type.
    Doran TJ; Derley L; Chapman J; McCaughan G; Painter D; Dorney S; Sheil AG
    Transplant Proc; 1992 Feb; 24(1):192-3. PubMed ID: 1539240
    [No Abstract]   [Full Text] [Related]  

  • 25. Lymphocyte subset analysis for the diagnosis of rejection and infection in recipients of liver transplants.
    Jindal RM; Greer G; Popescu I; Sidner RA
    Am Surg; 1999 Jan; 65(1):77-80. PubMed ID: 9915538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute rejection of hepatic allografts from HLA-DR13 (Allele DRB1(*)1301)-positive donors.
    Oertel M; Berr F; Schröder S; Schwarz R; Tannapfel A; Wenzke M; Lamesch P; Hauss J; Kohlhaw K
    Liver Transpl; 2000 Nov; 6(6):728-33. PubMed ID: 11084059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperacute rejection in liver transplantation: morphological and clinical characteristics.
    Cienfuegos JA; Pardo F; Hernández JL; Camps J; Quiroga J; Pardo J
    Transplant Proc; 1992 Feb; 24(1):141-2. PubMed ID: 1539213
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis B recurrence in relation to immunosuppression and acute allograft rejection.
    Platz KP; Mueller AR; Haller GW; Naumann U; Berg T; Fukomoto T; Lemmens HP; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3236-7. PubMed ID: 8962252
    [No Abstract]   [Full Text] [Related]  

  • 29. Low level of interleukin 10 synthesis during liver allograft rejection.
    Conti F; Boulland ML; Leroy-Viard K; Chereau C; Dousset B; Soubrane O; Weill B; Calmus Y
    Lab Invest; 1998 Oct; 78(10):1281-9. PubMed ID: 9800954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience in therapy of chronic liver allograft rejection.
    Charco R; Ruiz C; Allende E; Balsells J; Lazaro JL; Murio E; Bilbao I; Gifre E; Margarit C
    Transplant Proc; 1995 Aug; 27(4):2293-4. PubMed ID: 7652811
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunosuppression in liver transplantation.
    Cattral MS; Lilly LB; Levy GA
    Semin Liver Dis; 2000; 20(4):523-31. PubMed ID: 11200420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The significance and expresssion of fractalkine in acute rejection after rat orthotopic liver transplantation].
    Meng K; Song Z; Zhou X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 May; 21(5):528-31. PubMed ID: 17578296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changing perspectives on the role of corticosteroids after liver transplantation.
    Lucey MR
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S58-63. PubMed ID: 10431018
    [No Abstract]   [Full Text] [Related]  

  • 34. The pattern of rejection and susceptibility to different kinds of immunosuppression after combined liver, duodenum, and pancreas transplantation in swine--immunosuppressive drugs versus ex vivo immunomodulation of the allograft.
    Saito S; Fujiwara T; Sakagami K; Kobayashi N; Takaishi Y; Orita K
    Transplant Proc; 1995 Feb; 27(1):518-9. PubMed ID: 7533420
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunosuppression, cancer, and the long-term outcomes after liver transplantation: can we do better?
    Abraham JM; Thompson JA
    Liver Transpl; 2010 Jul; 16(7):809-11. PubMed ID: 20583078
    [No Abstract]   [Full Text] [Related]  

  • 36. BT563 significantly decreases sIL-2R plasma levels despite acute allograft rejection.
    Mueller AR; Platz KP; Steinmüller T; Nüssler N; Neumann U; Gerlach H; Stoll C; Bechstein WO; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3103-5. PubMed ID: 8962203
    [No Abstract]   [Full Text] [Related]  

  • 37. Quandaries and controversies in liver transplantation.
    Sheil AG
    Transplant Proc; 1992 Dec; 24(6):2375-8. PubMed ID: 1465801
    [No Abstract]   [Full Text] [Related]  

  • 38. Interleukin-15 production during liver allograft rejection in humans.
    Conti F; Frappier J; Dharancy S; Chereau C; Houssin D; Weill B; Calmus Y
    Transplantation; 2003 Jul; 76(1):210-6. PubMed ID: 12865812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the graft as a source of donor-type microchimerism in liver transplant patients.
    Hisanaga M; Schlitt HJ; Hundrieser J; Nakajima Y; Kanehiro H; Nakano H; Pichlmayr R
    Transplant Proc; 1996 Apr; 28(2):1073-5. PubMed ID: 8623231
    [No Abstract]   [Full Text] [Related]  

  • 40. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
    Sher LS; Cosenza CA; Petrovic LM; Rojter S; Hoffman A; Lopez RR; Meehan M; Pan SH; Vierling J; Makowka L
    Transplant Proc; 1996 Apr; 28(2):1011-3. PubMed ID: 8623212
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.